Get your message to the right audience
VarSome.com gets over 500 000 page views per month by Healthcare Professionals across six continents, allowing you to get your message in front of your target audience.
Genetically supported drug targets can significantly increase the chances of approval. If you have a genetic biomarker, VarSome Insights can make it faster, cheaper, and more efficient to find patients based on molecular profile.
VarSome.com is home to one of the world's most comprehensive databases of human genome variant information. Clinicians across six continents use VarSome.com to classify and interpret genetic variants to support diagnoses.
Over 87% of VarSome users have consented to have their information shared for relevant clinical studies or approved therapies. VarSome Insights allows you to see which clinicians have been investigating your genes of interest, including their:
VarSome.com gets over 500 000 page views per month by Healthcare Professionals across six continents, allowing you to get your message in front of your target audience.
Work in real-time with information from one of the world's largest communities of clinical geneticists and connect with them to support your clinical programs.
With more than 87% of the VarSome.com users consenting to be contacted about relevant trials and therapies, you can reach out to healthcare professionals in your target regions.
"We had another person agree to participate in our clinical trial. That's a great record of success."
"We look forward to leveraging Saphetor's innovative approach to bring together the global genomics community to build awareness in our rare disease program."
"Traditional prevalence efforts are usually a costly and timely endeavor. Inferred prevalence may circumvent this spend during early development efforts."
VarSome Suite is brought to you by Saphetor SA.
© 2024 Saphetor SA – All Rights Reserved.